Epidemiology of cysticercosis and neurocysticercosis

被引:21
作者
Bouteille, B. [1 ]
机构
[1] CHU Dupuytren, Serv Parasitol Mycol, 2 Ave Martin Luther King, F-87042 Limoges, France
来源
MEDECINE ET SANTE TROPICALES | 2014年 / 24卷 / 04期
关键词
Taenia solium; cysticercosis; neurocysticercosis; epilepsy; epidemiology;
D O I
10.1684/mst.2014.0378
中图分类号
R188.11 [热带医学];
学科分类号
摘要
Within the genus Taenia, three species are human parasites: T. solium, T. saginata and a new uncommon species, T. asiatica, described recently in Asia. T. saginata and T. solium live as adult tapeworms in human intestines, where they cause taeniasis. T. saginata is widely present worldwide, in all regions where cattle are bred. T. solium is endemic in many countries where livestock and consumption of pigs are common. Cattle and pigs become infected by ingesting eggs causes about 50,000 deaths each year. Its most frequent clinical manifestations are seizures, intracranial hypertension, neurological deficits, and sometimes psychiatric manifestations. It is also responsible for more than 50% of the cases of late-onset epilepsy in developing countries. The T. solium taeniasis/cysticercosis complex is endemic in many developing countries in sub-Saharan Africa, Latin America, and Asia. Although T. solium had virtually disappeared in developed countries due to industrialization, improved methods of husbandry, and health checks, cysticercosis and neurocysticercosis are diagnosed anew in North America, Europe and Australia due to increased immigration from endemic areas. Cysticercosis is considered an eradicable disease. Although theoretically feasible, this concept has been replaced by projects to control and reduce the impact of cysticercosis on human health (through mass treatment of people, veterinary control of pigs, improved farming techniques, and health education).
引用
收藏
页码:367 / 374
页数:8
相关论文
共 50 条
  • [41] Neurocysticercosis
    Del Brutto, Oscar H.
    NEUROHOSPITALIST, 2014, 4 (04) : 205 - 212
  • [42] New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries
    Carpio, Arturo
    Fleury, Agnes
    Kelvin, Elizabeth A.
    Romo, Matthew L.
    Abraham, Ronaldo
    Tellez-Zenteno, Jose
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (10) : 743 - 747
  • [43] The prevalence of and contributors to neurocysticercosis in endemic regions
    Ta, Ryan
    Blond, Benjamin N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 441
  • [44] Current Role of Surgery in the Treatment of Neurocysticercosis
    Filho, Pedro Tadao Hamamoto
    Norcia, Luiz Fernando
    Fleury, Agnes
    Zanini, Marco Antonio
    PATHOGENS, 2024, 13 (03):
  • [45] Neurocysticercosis infection and disease-A review
    Gripper, Lucy B.
    Welburn, Susan C.
    ACTA TROPICA, 2017, 166 : 218 - 224
  • [46] Epilepsy and neurocysticercosis in a village in Huaraz, Peru
    Garcia, HH
    Talley, A
    Gilman, RH
    Zorrilla, L
    Pretell, J
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1999, 101 (04) : 225 - 228
  • [47] Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?
    Garcia, Hector H.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (03) : 295 - 298
  • [48] Paediatric neurocysticercosis: two case reports
    Frieiro-Dantas, Carla
    Serramito-Garcia, Ramon
    Reyes-Santias, Rosa M.
    Rico-Cotelo, Maria
    Allut, Alfredo G.
    Gelabert-Gonzalez, Miguel
    REVISTA DE NEUROLOGIA, 2013, 56 (02) : 86 - 90
  • [49] Cestode Infestations Hydatid Disease and Cysticercosis
    Brunetti, Enrico
    White, A. Clinton, Jr.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (02) : 421 - +
  • [50] Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis
    Sotelo, Julio
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (06) : 529 - 535